Serplulimab structure
|
Common Name | Serplulimab | ||
|---|---|---|---|---|
| CAS Number | 2231029-82-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SerplulimabSerplulimab is humanized monoclonal anti-PD-1 antibody[1]. |
| Name | Serplulimab |
|---|
| Description | Serplulimab is humanized monoclonal anti-PD-1 antibody[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141. |
| No Any Chemical & Physical Properties |